Seeing Is Believing
Currently out of the existing stock ratings of Derik De Bruin, 21 are a SELL (16.94%), 54 are a HOLD (43.55%), 49 are a BUY (39.52%).
Analyst Derik De Bruin, carries an average stock price target met ratio of 68.54% that have a potential upside of 14.46% achieved within 123 days. Previously, Derik De Bruin worked at BAML.
Derik De Bruin’s has documented 248 price targets and ratings displayed on 31 stocks. The coverage was on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on WAT, Waters at 13-Feb-2025.
Analyst best performing recommendations are on TLIS (TALIS BIOMEDICAL CORP).
The best stock recommendation documented was for TLIS (TALIS BIOMEDICAL CORP) at 3/16/2022. The price target of $22.5 was fulfilled within 2 days with a profit of $3 (15.38%) receiving and performance score of 76.92.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$156
$76 (95.00%)
$184
18 days ago
(11-Mar-2025)
0/6 (0%)
$71.48 (84.57%)
Hold
$115
$35 (43.75%)
$135
18 days ago
(11-Mar-2025)
3/19 (15.79%)
$30.48 (36.06%)
15
Hold
$136
$56 (70.00%)
$150
1 months 18 days ago
(11-Feb-2025)
2/8 (25%)
$35.32 (35.08%)
71
Sell
$100
$20 (25.00%)
$130
1 months 19 days ago
(10-Feb-2025)
16/16 (100%)
$-4.99 (-4.75%)
142
Buy
$190
$110 (137.50%)
$185
1 months 19 days ago
(10-Feb-2025)
4/19 (21.05%)
$85.01 (80.97%)
94
Which stock is Derik De Bruin is most bullish on?
Which stock is Derik De Bruin is most reserved on?
What Year was the first public recommendation made by Derik De Bruin?